A Trial of AXS-05 in Patients With Major Depressive Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Depression, Major Depressive Disorder

In brief

A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of AXS-05 in patients with major depressive disorder (MDD).

Key facts

Study ID
NCT04019704
Run by
Axsome Therapeutics, Inc.
People needed
327
Starts
2019-06-20
Expected to finish
2019-12-05
Last updated by the study team
2022-10-12

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.